GMO Prime Strategy Cash Flow Statement

Financials in millions JPY. Fiscal year is December - November.

Millions JPY. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Net Income	144	212	269	-	-
Depreciation & Amortization	11	9	8	-	-
Loss (Gain) From Sale of Investments	-	-	-3	-	-
Other Operating Activities	-52	-66	-134	-	-
Change in Accounts Receivable	-16	3	-9	-	-
Change in Inventory	7	-7	-	-	-
Change in Accounts Payable	7	10	-3	-	-
Change in Other Net Operating Assets	15	-33	27	-	-
Operating Cash Flow	116	128	155	-	-
Operating Cash Flow Growth	-9.38%	-17.42%	-	-	-
Capital Expenditures	-1	-8	-	-	-
Divestitures	-	-	1	-	-
Sale (Purchase) of Intangibles	-19	-3	-4	-	-
Investment in Securities	-50	-30	-	-	-
Other Investing Activities	-	3	-17	-	-
Investing Cash Flow	-70	-38	-20	-	-
Long-Term Debt Issued	-	100	-	-	-
Long-Term Debt Repaid	-41	-80	-128	-	-
Net Debt Issued (Repaid)	-41	20	-128	-	-
Issuance of Common Stock	17	30	778	-	-
Repurchase of Common Stock	-65	-	-	-	-
Common Dividends Paid	-74	-68	-	-	-
Other Financing Activities	1	1	-20	-	-
Financing Cash Flow	-162	-17	630	-	-
Foreign Exchange Rate Adjustments	2	-	1	-	-
Miscellaneous Cash Flow Adjustments	-	-1	1	-	-
Net Cash Flow	-114	72	767	-	-
Free Cash Flow	115	120	155	-	-
Free Cash Flow Growth	-4.17%	-22.58%	-	-	-
Free Cash Flow Margin	12.96%	14.00%	17.67%	-	-
Free Cash Flow Per Share	31.74	32.87	43.84	-	-
Cash Interest Paid	-	-	1	-	-
Cash Income Tax Paid	54	67	131	-	-
Levered Free Cash Flow	66	118.13	110.38	-	-
Unlevered Free Cash Flow	66	118.13	111	-	-
Change in Working Capital	13	-27	15	-	-